Director Declaration

Directorship Notification

London, UK, 21 April 2015: Pursuant to Listing Rule 9.6.14R (2), BTG plc (LSE: BTG), the specialist healthcare company, announces that CEO Louise Makin was appointed as a non-executive director of Woodford Patient Capital Trust plc on 13 February 2015. Woodford Patient Capital Trust plc was admitted to trading on the Main Market of the London Stock Exchange on 21 April 2015.

For further information contact:

BTG FTI Consulting

Andy Burrows, VP Corporate & Investor Relations Ben Atwell/Simon Conway

+44 (0)20 7575 1741; Mobile: +44 (0)7990 530 605 +44 (0)20 3727 1000

Stuart Hunt, Investor Relations Manager

+44 (0)20 7575 1582; Mobile: +44 (0)7815 778 536

About BTG

BTG is a growing international specialist healthcare company bringing to market innovative products in specialist areas of medicine to better serve doctors and their patients. We have a portfolio of Interventional Medicine products to advance the treatment of liver tumours, severe blood clots, varicose veins and advanced emphysema, and Specialty Pharmaceuticals that help patients overexposed to certain medications or toxins. Inspired by patient and physician needs, BTG is investing to expand its portfolio to address some of today's most complex healthcare challenges. To learn more about BTG, please visit: www.btgplc.com